Calistoga Hands the Keys to Gilead, Bets It Can Make Cancer a Chronic Disease Like HIV – Xconomy

Posted on March 11, 2011 by admin

Calistoga’s plan for 2011 was to move first into a pivotal study that could earn FDA approval of CAL-101 for indolent non-Hodgkin’s lymphoma, while starting a pivotal study for the chronic lymphocytic leukemia population later in 2011. Instead of … Bing News – Full Story →

Share

Related posts:

  1. Complete Information on Chronic Lymphocytic Leukemia
  2. CAL-101 in CLL chronic lymphocytic leukemia
  3. Recently released market study: Hodgkin Lymphoma Clinical Trials Review, Q4 2010 – PR Inside
  4. New study casts doubt on retrovirus link to cancer and chronic fatigue syndrome – Los Angeles Times
  5. Friends of Keith Hayes put together benefit concert to help with lymphoma medical expenses – Lubbock Avalanche-Journal
This entry was posted in Chronic Lymphocytic Leukemia and tagged , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>